ELAN Q2 2018 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$770M+7.2% YoY

Gross Profit

$289M37.6% margin

Operating Income

$37M4.8% margin

Net Income

-$63M-8.2% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

+4.6%

Cash Flow

Operating Cash Flow

$137M

Free Cash Flow

$113M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$8.6B

Total Liabilities

$991M

Stockholders' Equity

$7.6B

Cash & Equivalents

$321M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$770M	$719M	+7.2%
Gross Profit	$289M	$376M	-23.0%
Operating Income	$37M	$63M	-41.4%
Net Income	-$63M	-$64M	+2.3%